Articles tagged with Cancer Screening
Research suggests that adding a simple endorsement from a patient's GP practice to the invitation letter could increase the number of people taking the bowel cancer screening test by up to 40,000 annually. This would lead to an additional 61 cases of bowel cancer and 165 high or medium-risk polyps being detected each year.
Research by Michigan Medicine found that nearly 15% of colorectal cancer patients were diagnosed before age 50, often with more advanced disease. Younger patients had better survival rates due to aggressive treatment, suggesting the need for improved long-term survivorship resources.
A study of US data found that one in seven colorectal cancer patients is younger than 50 years old, often presenting with advanced stage disease. However, these patients tend to receive more aggressive therapy and have a slightly longer survival rate without recurrence.
New figures show that screening picks up the majority of bowel cancer cases at an early stage. Screening detected more than a third of bowel cancers at stage one and fewer than one in ten advanced to stage four. Patients whose cancers are picked up at an earlier stage have better chances of survival due to effective treatment.
Experts argue that cancer screening has never been shown to 'save lives' due to reduced overall mortality rates. Harms associated with screening, such as overdiagnosis and false positives, are significant concerns. The authors call for higher standards of evidence and consideration of harms in cancer screening.
A recent study published in The Journal of Urology found that reduced prostate needle biopsies are associated with a higher risk of being diagnosed with high-risk disease. This could lead to delayed diagnosis and potentially avoidable cancer deaths. The study's findings highlight the need for balanced screening approaches and more effe...
Cardiovascular disease is prevalent among adult survivors of childhood cancer, presenting at an earlier age and causing substantial morbidity. The American College of Physicians emphasizes the need for systematic assessment and potential value of routine physical exams to identify cardiac abnormalities.
A study published in JNCI Journal of the National Cancer Institute found that virtual colonoscopy had higher detection rates than traditional methods like FIT and OC. The researchers concluded that combination of lower attendance and higher detection rate makes CTC a key factor for optimization of its role in population screening.
A recent study involving one million patients found that follow-up times for abnormal screening exams were shorter for breast cancer than for colorectal and cervical cancers. The study characterized cancer screening practice variation across seven centers and noted the potential barriers to timely follow-up, including patient inconveni...
A new study from University Hospitals Case Medical Center found that making colonoscopy available at no cost to eligible Medicare beneficiaries did not increase the number of people who regularly undergo the procedure. In contrast, routine mammography screenings significantly increased following the Affordable Care Act's mandate for lo...
Improved screening and detection efforts have reduced cancer incidence and mortality rates in several common types of cancer in high-income countries. However, many low-and middle-income countries have seen a rise in cancer rates due to factors such as lifestyle changes and inadequate screening or prevention measures.
A breast screening program has been shown to prevent subsequent invasive cancer in women with ductal carcinoma in situ (DCIS), a very early form of breast cancer. The study analyzed data from over 5 million women and found that increased prior screen detection of DCIS was associated with a reduction in invasive cancers.
A city-wide initiative in NYC increased colorectal cancer screening colonoscopy rates from 42% to 62% and eliminated disparities based on race/ethnicity. The program included public education, outreach to healthcare providers, and culturally tailored campaigns to boost awareness and overcome hurdles to effective screening.
Two studies found a decline in early-stage prostate cancer incidence and PSA-based screening rates among men 50 years and older following the 2012 USPSTF screening recommendations. The decline was most pronounced in younger men, with significant reductions in PSA screening rates observed between 2010 and 2013.
A new stool DNA test has been found accurate in screening for colorectal cancer among Alaska Native people, a population with one of the world's highest rates of the disease. The test detected significantly more screen-relevant neoplasms than traditional fecal occult blood testing methods.
A large study found that high-grade DCIS detection rates increase with age, particularly among women over 65. The study suggests that standard DCIS therapy may not be effective in this age group and highlights the need for more research on the effectiveness of screening.
New risk profiling approach aims to detect GI cancers, such as oesophageal adenocarcinoma, in early stages. The five-tier strategy involves lifestyle changes, non-invasive testing, and genetic analysis to tailor screening and prevention options for each individual.
The American Cancer Society recommends starting annual mammography screening at age 45 for average-risk women. Women between 40-44 can choose to begin annual screening. Clinical breast examination is no longer recommended due to lack of clear evidence on its effectiveness in detecting breast cancer.
A recent study found that premenopausal women who received annual mammography screenings had smaller and less advanced tumors compared to those who received biennial screenings. In contrast, postmenopausal women did not show significant differences in tumor characteristics regardless of screening frequency.
Current 20- to 29-pack-year smokers are at similar risk for lung cancer as 30+ pack-year former smokers who meet current guidelines. The study's findings suggest caution when recommending LDCT screening to this group due to untested assumptions and potential harms.
Research finds that 43% of patients experience heightened emotional distress before LDCT screening, with one-third experiencing ongoing distress after results are released. Distress monitoring and clinical intervention are crucial for supporting the well-being of patients undergoing lung cancer screening.
A study by Cancer Research UK found that adding extras like gloves and 'poo catchers' to the bowel cancer screening kit can increase participation rates. The London study saw a rise in uptake from around 43% to 54% among 60-74 year olds, with nearly 26,000 extra people taking up screening in London alone.
A study published in Clinical Gastroenterology and Hepatology suggests that all relatives of individuals with colorectal cancer are at increased risk for this cancer, regardless of their age. The risk is highest among young first-degree relatives under 50 years old.
A researcher is calling for updated guidelines on colorectal cancer screening, citing evidence that most patients with a family history of the disease can stop aggressive screening at age 65. The study found that the risk of colorectal cancer diagnosis decreases with increasing age in patients with a family history.
A large national BCSC study found that computer-aided detection (CAD) of breast cancer screening does not improve accuracy or patient outcomes. CAD raised screening costs and increased false positives, but did not detect more cancers or improve outcomes for women in screening programs.
A large study found that computer-aided detection (CAD) for mammography did not improve diagnostic accuracy in radiologists' interpretations. Despite increased use and FDA approval, CAD's effectiveness was not supported by the results, leading to calls for reduced reimbursement or reconsideration of its continued coverage.
A recent study found that reduced prostate specific antigen (PSA) screening led to a decline in intermediate and high-risk prostate cancer diagnoses by 28% over a year. However, this reduction also resulted in delayed diagnoses of important cancers in men who may benefit from treatment, according to investigators.
A new bowel cancer screening test has seen low uptake in pilot areas, with only half of those invited taking the opportunity. Despite its potential to reduce cases by up to 33%, more men than women took the test, and people from poorer neighbourhoods were less likely to participate.
A new study reveals that nearly half of testicular cancer risk comes from inherited genetic faults, significantly higher than in most other cancer types. The research suggests testing for specific genetic variants could help identify patients at substantially increased risk and potentially lead to prevention methods.
Researchers at OU and Mercy Hospital OKC are developing two new short-term breast cancer risk prediction approaches to increase detection of breast MRI screenings. They aim to identify high-risk women with mammography-occult cancers and reduce repeated negative MRI screenings among those with elevated risk.
Patients whose colorectal cancer is detected during a screening colonoscopy tend to live longer than those who wait until symptoms appear. The study found that these patients had cancer at an earlier stage and were more likely to survive beyond the study period, with about 55% surviving beyond the time of diagnosis.
A review of randomised trials on cancer screening finds that mammographic screening may not reduce breast cancer mortality as expected. The study suggests that the benefits of mammography screening are likely to have been overestimated due to an unconventional statistical method used in earlier trials.
A study found that increased screening mammography was associated with more diagnoses of small breast cancers, but not significant changes in mortality or larger cancer incidence, suggesting overdiagnosis
Researchers at MD Anderson Cancer Center have identified a potential non-invasive diagnostic tool for early pancreatic cancer detection. Glypican-1-enriched circulating exosomes were found to be present in small amounts of serum from patients with pancreatic cancer, showing high specificity and sensitivity. Early detection of pancreati...
A new study published in Radiology found that annual low-dose computed tomography (CT) screening can safely monitor people with nonsolid lung nodules, reducing the need for unnecessary surgery and additional imaging. Nonsolid nodules are visible on CT scans of the chest and management is challenging.
A new study found annual low-dose CT screening to be safe and effective for identifying pre-cancerous lung nodules. The study identified cases of cancer in participants with nonsolid lung nodules, which can progress to invasive cancer.
A large clinical trial led by The Ottawa Hospital and the University of Ottawa found that CT scans do not improve cancer detection in people with unexplained blood clots. Approximately four percent of patients from each group were diagnosed with cancer within the next year, with no difference in cancer-associated deaths.
The Harvard Medical School Cancer Biology and Therapeutics Training Program will provide specialized education and training in cancer research and treatment. The one-year, nonclinical blended-learning certificate program is designed to promote a deeper understanding of cancer biology, diagnosis, and personalized treatments.
A national survey found that only one in ten Australians report being told about the risk of overdiagnosis by their doctors, while over 90% believe people should be informed. Overdiagnosis occurs when someone is diagnosed with a disease that will never cause harm due to unnecessary labelling and treatment.
A study published in Annals of Internal Medicine suggests that women with extremely dense breasts do not necessarily need additional imaging after a normal mammogram. However, those with high-risk dense breasts should discuss supplemental screening strategies with their doctors. The American College of Physicians advises 'smarter' canc...
Researchers at University Hospitals Cleveland Medical Center found a new non-invasive stool DNA testing method comparable to colonoscopy for detecting large polyps in African Americans. The study suggests this technology may improve colon cancer screening rates and decrease mortality.
The American College of Physicians recommends screening for five common cancers: breast, colorectal, ovarian, prostate, and cervical. High-intensity screening may do more harm than good due to over-diagnosis and overtreatment. ACP advises focusing on tests that improve health and avoid harms.
A five-month media campaign in Florida's poorest counties increased black men's awareness of mouth and throat cancer, leading to a 13% rise in first-time screenings. The campaign, designed by UF Health researchers, aimed to reverse the health inequity faced by black men, who have lower survival rates due to delayed diagnosis.
A recent study found that women in states without Medicaid expansion are less likely to receive breast and cervical cancer screenings compared to those in expanding states. The disparity is significant, with uninsured women facing a 7.9% lower rate of mammograms and a 4.9% lower rate of Pap tests.
Digital breast tomosynthesis (DBT) increases cancer detection rates among women with dense breasts, with a significant improvement seen in those with dense breasts called back for mass and asymmetry. The study found a striking increase in detection among these groups, offering new insights into DBT's effectiveness.
Researchers have identified methylated DNA markers in blood samples with 80% accuracy, enabling potential non-invasive screening for cancer. The discovery could lead to earlier diagnosis and improved patient outcomes for rare cancers like pancreatic cancer.
Most breast and general surgeons still advocate for annual mammography starting at age 40, despite a 2009 USPSTF recommendation to screen biennially from 50 to 74. Researchers found 88% of breast surgeons and 82% of general surgeons recommend annual screenings.
A magnetic resonance imaging (MRI)-based screening program identified pancreatic lesions in 40% of high-risk patients, with 5 requiring surgery. The study suggests that MRI can detect cancer or premalignant lesions with good accuracy, reducing costs and increasing availability compared to more aggressive methods.
A new test developed by University of Central Florida scientist Qun Huo uses gold nanoparticles to detect cancer biomarkers, providing more accurate and earlier detection of prostate cancer. The test is cost-effective and has shown promising results in pilot studies, outperforming the current PSA screen.
The American Cancer Society's new report highlights disparities in cancer prevention and early detection efforts, including underutilized screening for colorectal and cervical cancers. Meanwhile, tobacco use remains a major cause of preventable disease and premature death, with wide variation by education and race/ethnicity.
The Global Cancer Project Map is an online resource connecting the global cancer community, enabling access to cancer projects and expertise. The map covers a range of projects, from prevention to palliative care, and aims to reduce health disparities and strengthen human capital in underserved areas.
A new study estimates that increasing screening rates to 80% in the US by 2018 would prevent 21,000 colorectal cancer deaths annually by 2030. The initiative aims to boost screening from 58% in 2013 to 80% in 2018.
A UK survey found that people's willingness to accept overdetection in cancer screening varies greatly, depending on the level of benefit and perceived harms. The study revealed that up to 14% would accept overdetection in the entire population, with median acceptability ranging from 113 to 150 cases.
Research highlights psychology's contributions to cancer risk reduction, treatment adherence, quality of life, and survivorship. Psychological science helps individuals modify unhealthy behaviors that can lead to disease, and enhances the lives of people who have survived or are living with cancer.
Research reveals that adults in Ontario with IDD are nearly twice as likely not to be up-to-date on colorectal tests compared to their non-IDD counterparts. The study highlights the need for targeted interventions to make cancer screening more equitable in this population, where chronic conditions like cancer increase with age.
Experts suggest that targeted screening programs for middle-aged and older patients using newer diagnostic tools could significantly reduce melanoma mortality rates. Studies in Australia and Germany have shown a substantial decrease in melanoma-related deaths after implementing comprehensive skin cancer screening programs.
Research presented at the American Stroke Association's International Stroke Conference 2015 found that stroke survivors have a higher annual rate of age-adjusted cancer incidence compared to the general population. Additionally, stroke survivors who develop cancer are more than three times likely to die compared to those without cancer.
A Cancer Research UK study found that nine in 10 people think cancer screening is 'almost always a good idea', despite low uptake. The researchers highlight the need for clearer information on risks and benefits to encourage informed decision-making.
A recent retrospective study found that Lung-RADS guidelines generated fewer false-positives than the National Lung Screening Trial, reducing unnecessary follow-up testing. The guidelines provide structured reporting tools for practices to benchmark performance and improve lung cancer screening's cost-effectiveness.
Researchers used the mortality-to-incidence ratio to identify global disparities in colorectal cancer screening and treatment. Countries with lower-than-expected ratios have strong national health systems with formal screening programs.